Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Saved in:
| Title: | Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. |
|---|---|
| Authors: | Rudin, Charles M1 rudinc@mskcc.org, Pietanza, M Catherine1, Bauer, Todd M2,3, Ready, Neal4, Morgensztern, Daniel5, Glisson, Bonnie S6, Byers, Lauren A6, Johnson, Melissa L2,3, IIIBurris, Howard A2,3, Robert, Francisco7, Han, Tae H8, Bheddah, Sheila8, Theiss, Noah9, Watson, Sky9, Mathur, Deepan9, Vennapusa, Bharathi9, Zayed, Hany8, Lally, Satwant8, Strickland, Donald K3, Govindan, Ramaswamy5 |
| Source: | Lancet Oncology. Jan2017, Vol. 18 Issue 1, p42-51. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 120475021 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rudin%2C+Charles+M%22">Rudin, Charles M</searchLink><relatesTo>1</relatesTo><i> rudinc@mskcc.org</i><br /><searchLink fieldCode="AR" term="%22Pietanza%2C+M+Catherine%22">Pietanza, M Catherine</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Bauer%2C+Todd+M%22">Bauer, Todd M</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Ready%2C+Neal%22">Ready, Neal</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Morgensztern%2C+Daniel%22">Morgensztern, Daniel</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Glisson%2C+Bonnie+S%22">Glisson, Bonnie S</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Byers%2C+Lauren+A%22">Byers, Lauren A</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Johnson%2C+Melissa+L%22">Johnson, Melissa L</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22IIIBurris%2C+Howard+A%22">IIIBurris, Howard A</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Robert%2C+Francisco%22">Robert, Francisco</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Han%2C+Tae+H%22">Han, Tae H</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Bheddah%2C+Sheila%22">Bheddah, Sheila</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Theiss%2C+Noah%22">Theiss, Noah</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Watson%2C+Sky%22">Watson, Sky</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Mathur%2C+Deepan%22">Mathur, Deepan</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Vennapusa%2C+Bharathi%22">Vennapusa, Bharathi</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Zayed%2C+Hany%22">Zayed, Hany</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Lally%2C+Satwant%22">Lally, Satwant</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Strickland%2C+Donald+K%22">Strickland, Donald K</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Govindan%2C+Ramaswamy%22">Govindan, Ramaswamy</searchLink><relatesTo>5</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Jan2017, Vol. 18 Issue 1, p42-51. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=120475021 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(16)30565-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 42 Titles: – TitleFull: Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rudin, Charles M – PersonEntity: Name: NameFull: Pietanza, M Catherine – PersonEntity: Name: NameFull: Bauer, Todd M – PersonEntity: Name: NameFull: Ready, Neal – PersonEntity: Name: NameFull: Morgensztern, Daniel – PersonEntity: Name: NameFull: Glisson, Bonnie S – PersonEntity: Name: NameFull: Byers, Lauren A – PersonEntity: Name: NameFull: Johnson, Melissa L – PersonEntity: Name: NameFull: IIIBurris, Howard A – PersonEntity: Name: NameFull: Robert, Francisco – PersonEntity: Name: NameFull: Han, Tae H – PersonEntity: Name: NameFull: Bheddah, Sheila – PersonEntity: Name: NameFull: Theiss, Noah – PersonEntity: Name: NameFull: Watson, Sky – PersonEntity: Name: NameFull: Mathur, Deepan – PersonEntity: Name: NameFull: Vennapusa, Bharathi – PersonEntity: Name: NameFull: Zayed, Hany – PersonEntity: Name: NameFull: Lally, Satwant – PersonEntity: Name: NameFull: Strickland, Donald K – PersonEntity: Name: NameFull: Govindan, Ramaswamy IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 14702045 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Lancet Oncology Type: main |
| ResultId | 1 |
